Clinical Trials Browser

Phase 1 × Terminated × Bronchiolitis Obliterans Syndrome × Clear all

Bronchiolitis Obliterans Syndrome, Leukemia

NCT01663766 2021-08-19

Phase I Study of Milatuzumab for Graft Versus Host Disease

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia

Phase I Study of Milatuzumab for Graft Versus Host Disease